1JQ7 image
Deposition Date 2001-08-03
Release Date 2001-09-12
Last Version Date 2024-11-20
Entry Detail
PDB ID:
1JQ7
Title:
HCMV protease dimer-interface mutant, S225Y complexed to Inhibitor BILC 408
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.33
R-Value Work:
0.26
Space Group:
P 41 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:ASSEMBLIN
Gene (Uniprot):UL80
Mutagens:A143Q, S225Y
Chain IDs:A, B
Chain Length:256
Number of Molecules:2
Biological Source:Human herpesvirus 5
Ligand Molecules
Peptide-like Molecules
PRD_000283
Primary Citation
Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease.
Nat.Struct.Biol. 8 810 817 (2001)
PMID: 11524687 DOI: 10.1038/nsb0901-810

Abstact

Biochemical studies indicate that dimerization is required for the catalytic activity of herpesvirus proteases, whereas structural studies show a complete active site in each monomer, away from the dimer interface. Here we report kinetic, biophysical and crystallographic characterizations of structure-based mutants in the dimer interface of human cytomegalovirus (HCMV) protease. Such mutations can produce a 1,700-fold reduction in the kcat while having minimal effects on the K(m). Dimer stability is not affected by these mutations, suggesting that dimerization itself is insufficient for activity. There are large changes in monomer conformation and dimer organization of the apo S225Y mutant enzyme. However, binding of an activated peptidomimetic inhibitor induced a conformation remarkably similar to the wild type protease. Our studies suggest that appropriate dimer formation may be required to indirectly stabilize the protease oxyanion hole, revealing a novel mechanism for dimerization to regulate enzyme activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures